Literature DB >> 1283533

Accelerated expression of cholecystokinin gene in the brain of rats rendered tolerant to morphine.

Y Zhou1, Y H Sun, Z W Zhang, J S Han.   

Abstract

Results from behavioural studies have shown that central cholecystokinin octapeptide (CCK-8) is a powerful antagonist against opioid effects and that an increased release of central CCK-8 plays an important role in the mechanisms of tolerance to morphine analgesia. No information is available concerning the rate of biosynthesis of CCK-8 in response to chronic morphine administration. Blot hybridization experiments made in the present study revealed a marked increase in preproCCK mRNA in the brain of rats receiving chronic morphine treatment for 1, 3 and 6 days, showing an increment of 52% (p < 0.05), 62% (p < 0.05) and 97% (p < 0.01) respectively. The results suggest that an acceleration of the expression of the CCK gene during long-term morphine treatment might constitute one of the mechanisms for morphine tolerance.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1283533     DOI: 10.1097/00001756-199212000-00022

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  8 in total

1.  Similar decrease in spontaneous morphine abstinence by methadone and RB 101, an inhibitor of enkephalin catabolism.

Authors:  F Ruiz; M C Fournié-Zaluski; B P Roques; R Maldonado
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

2.  Opposite role of CCKA and CCKB receptors in the modulation of endogenous enkephalin antidepressant-like effects.

Authors:  C Smadja; R Maldonado; S Turcaud; M C Fournie-Zaluski; B P Roques
Journal:  Psychopharmacology (Berl)       Date:  1995-08       Impact factor: 4.530

Review 3.  Association of enkephalin catabolism inhibitors and CCK-B antagonists: a potential use in the management of pain and opioid addiction.

Authors:  B P Roques; F Noble
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

4.  Cholecystokinin in the rostral ventromedial medulla mediates opioid-induced hyperalgesia and antinociceptive tolerance.

Authors:  Jennifer Y Xie; David S Herman; Carl-Olav Stiller; Luis R Gardell; Michael H Ossipov; Josephine Lai; Frank Porreca; Todd W Vanderah
Journal:  J Neurosci       Date:  2005-01-12       Impact factor: 6.167

Review 5.  Complications of long-term opioid therapy for management of chronic pain: the paradox of opioid-induced hyperalgesia.

Authors:  D Eric Brush
Journal:  J Med Toxicol       Date:  2012-12

6.  Exogenous and endogenous opioid-induced pain hypersensitivity in different rat strains.

Authors:  Emilie Laboureyras; Frédéric Aubrun; Maud Monsaingeon; Jean-Benoît Corcuff; Jean-Paul Laulin; Guy Simonnet
Journal:  Pain Res Manag       Date:  2014-05-16       Impact factor: 3.037

7.  Over-expression of CCK1 Receptor Reverse Morphine Dependence.

Authors:  Lijing Hao; Di Wen; Hongyan Gou; Feng Yu; Bin Cong; Chunling Ma
Journal:  Int J Pept Res Ther       Date:  2018-04-02       Impact factor: 1.931

Review 8.  The Involvement of Descending Pain Inhibitory System in Electroacupuncture-Induced Analgesia.

Authors:  Qiuyi Lv; Fengzhi Wu; Xiulun Gan; Xueqin Yang; Ling Zhou; Jie Chen; Yinjia He; Rong Zhang; Bixiu Zhu; Lanying Liu
Journal:  Front Integr Neurosci       Date:  2019-08-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.